Page last updated: 2024-11-13

6-phosphogluconolactone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6-phosphogluconolactone: an electrophilic compound [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

6-O-phosphonato-D-glucono-1,5-lactone(2-) : Dianion of 6-O-phosphono-D-glucono-1,5-lactone arising from deprotonation of the phosphate OH groups; major species at pH 7.3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID46926335
CHEBI ID57955
MeSH IDM0294197

Synonyms (10)

Synonym
d-glucono-delta-lactone 6-phosphate
D-6-P-GLUCONO-DELTA-LACTONE ,
6-phosphogluconolactone
6-phospho d-glucono-1,5-lactone
[(2r,3s,4s,5r)-3,4,5-trihydroxy-6-oxooxan-2-yl]methyl phosphate
6-o-phosphonato-d-glucono-1,5-lactone dianion
CHEBI:57955
6-o-phosphonato-d-glucono-1,5-lactone(2-)
[(2r,3s,4s,5r)-3,4,5-trihydroxy-6-oxotetrahydro-2h-pyran-2-yl]methyl phosphate
Q27125080
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
Saccharomyces cerevisiae metaboliteAny fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
organophosphate oxoanionAn organic phosphoric acid derivative in which one or more oxygen atoms of the phosphate group(s) has been deprotonated.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (14)

PathwayProteinsCompounds
pentose phosphate pathway315
pentose phosphate pathway (oxidative branch) I09
Renz2020 - GEM of Human alveolar macrophage with SARS-CoV-20490
pentose phosphate pathway (oxidative branch)39
NAD/NADP-NADH/NADPH cytosolic interconversion (yeast)526
superpathway NAD/NADP - NADH/NADPH interconversion (yeast)1031
formaldehyde oxidation I124
superpathway of glycolysis and the Entner-Doudoroff pathway2358
Entner-Doudoroff pathway I1639
heterolactic fermentation737
pentose phosphate pathway929
pentose phosphate pathway (oxidative branch) I811
superpathway of glucose and xylose degradation029
superpathway NAD/NADP - NADH/NADPH interconversion1129
NAD/NADP-NADH/NADPH cytosolic interconversion626
glucose and xylose degradation2328

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (7.69)18.2507
2000's6 (46.15)29.6817
2010's4 (30.77)24.3611
2020's2 (15.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 45.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index45.65 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index63.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (45.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]